On this page
In short
This website provides general information about regenerative and aesthetic medicine. It is not medical advice and is not a substitute for consultation with a qualified physician familiar with your medical history.
01Information is not medical advice
Copy, case descriptions, statistics, and explanatory content published on morphoturkiye.com are intended to help you understand the services we coordinate and the general landscape of regenerative and aesthetic medicine.
Nothing on this website:
- Constitutes medical diagnosis or treatment recommendation for any specific individual.
- Replaces consultation with your general practitioner (GP) or a qualified specialist.
- Should be relied on to defer, avoid, or substitute treatment advised by your local physician.
Always consult a qualified physician familiar with your medical history before making treatment decisions.
02Individual outcomes vary
Testimonials, indicative outcomes, and illustrative case descriptions shown on morphoturkiye.com describe individual experiences. They are not promises, typical results, or efficacy claims.
Outcomes of regenerative and aesthetic treatments are influenced by:
- Age, sex, weight, and general health.
- Severity, chronicity, and biological characteristics of the condition.
- Prior treatments, medications, and co-morbidities.
- Adherence to pre- and post-procedure protocols.
- Factors beyond clinical control (genetics, lifestyle, environmental).
Your treating clinician will discuss realistic expectations with you during consultation, based on your specific case. We make no guarantee of any specific medical outcome for any individual patient.
03Stem cell therapy — regulatory status
Stem cell therapy is regulated differently in different jurisdictions. If you are considering treatment coordinated through Morpho Health, you should understand the regulatory context:
In Türkiye
Stem cell therapy is regulated by the Turkish Ministry of Health under specific protocols for autologous and approved allogeneic applications. Our partner facilities operate only within these approved protocols and maintain documentation for cell sourcing, preparation, dosing, and administration.
In the United Kingdom
Many stem cell applications are not licensed as medicinal products by the MHRA (UK Medicines and Healthcare products Regulatory Agency). Specifically, autologous and allogeneic stem cell therapies for orthopaedic and general regenerative indications are generally not MHRA-licensed.
Morpho Health is not a UK-licensed clinical provider. Treatment you receive in Türkiye is outside UK MHRA oversight. This does not mean treatment is unsafe; it means the regulatory framework is different. We strongly recommend involving your UK GP or specialist in your decision, and we provide all documentation required for that conversation.
In the European Union
Similar considerations apply to most EU member states. EU-specific regulatory status varies; patients resident in the EU should consult their local clinician and regulator where appropriate.
04All treatments carry risk
All medical and aesthetic procedures carry risks. These may include, without limitation:
- Pain, swelling, bruising, or discomfort during or after the procedure.
- Infection at the site of injection or incision.
- Allergic or adverse reaction to injected material, anaesthetic, or consumables.
- Unintended aesthetic outcome, including asymmetry or dissatisfaction with results.
- Need for revision or follow-up treatment.
- Rare but serious complications including systemic reaction, vascular events, or prolonged recovery.
- No response to treatment, or a response below your personal expectations.
Full, procedure-specific risk information will be provided in writing during clinical consultation before you consent to any procedure. You should read this, ask questions, and discuss with your local physician.
05Eligibility screening is a safety feature
Our partner clinicians conduct an eligibility assessment that typically includes:
- Review of history, medications, and prior treatments.
- Review of recent imaging (MRI, X-ray, ultrasound as relevant).
- Blood work and laboratory tests where indicated.
- Pre-consultation or in-person clinical examination.
We will decline coordination where the clinical picture does not support a reasonable expectation of benefit, or where travel or the procedure itself would be inappropriate for your circumstances. This is a safety feature, not a service limitation.
06Travel & post-treatment care
Medical tourism involves travel-related considerations that do not apply to local treatment:
- Post-procedure air travel restrictions (most surgical procedures require a minimum waiting period before flying).
- Climate and time-zone adjustments during recovery.
- Physical separation from your regular care team and usual support network.
- Need for an agreed local physician to handle any issues that arise at home.
We include a 12-week structured remote aftercare programme with every package. Even so, you should have a named local physician available to examine you in person if issues arise between scheduled remote follow-ups. We will coordinate handover to that physician and share the full documentation they need.
07Emergencies
Do not use this website for medical emergencies
If you are experiencing a medical emergency, do not submit an enquiry form or wait for a response. Contact your local emergency services:
United Kingdom: 999 · European Union: 112 · Türkiye: 112 · United States: 911
Or attend the nearest Accident & Emergency (ER) department.
08Advertising standards
We aim to comply with the UK Advertising Standards Authority (ASA) CAP Code for medical and cosmetic advertising, including:
- No before-and-after imagery for cosmetic surgical procedures on open-web channels. Outcome galleries are shared privately during consultation, only with the explicit written consent of each patient pictured.
- No misleading efficacy claims or unsubstantiated statistics.
- Clear disclosure of the role of Morpho Health as a coordinator, not a clinical provider.
- Reasonable, realistic representation of outcomes.
If you identify advertising content on our website or third-party placements that does not meet these standards, please email contact@morphoturkiye.com so we can review and correct it.
09Questions
If you have questions about the clinical or regulatory aspects of treatments we coordinate — including UK MHRA position, partner accreditations, specific procedure risks, or post-treatment care — please email contact@morphoturkiye.com. A coordinator will route your question to the appropriate clinician if needed.
This Medical Disclaimer is read together with our Terms of Service and Privacy Policy.